Education
About Us
Working with TipRanks
Follow Us
Prestige Consumer Healthcare (PBH)
NYSE:PBH
PBH Stock Chart & Stats
$63.96
-$0.15(-0.20%)
At close: 4:00 PM EST
$63.96
-$0.15(-0.20%)
Day’s Range― - ―
52-Week Range$57.25 - $90.04
Previous CloseN/A
Volume57.25K
Average Volume (3M)456.76K
Market Cap
$3.08B
Enterprise Value$4.00B
Total Cash (Recent Filing)$119.11M
Total Debt (Recent Filing)$1.04B
Price to Earnings (P/E)15.9
Beta0.33
Next Earnings
Feb 05, 2026EPS Estimate
1.14Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.07
Shares Outstanding48,084,010
10 Day Avg. Volume504,397
30 Day Avg. Volume456,760
Financial Highlights & Ratios
PEG Ratio7.62
Price to Book (P/B)2.33
Price to Sales (P/S)3.76
P/FCF Ratio17.56
Enterprise Value/Market Cap1.30
Enterprise Value/Revenue3.60
Enterprise Value/Gross Profit6.38
Enterprise Value/Ebitda11.20
Forecast
1Y Price Target
$77.00Price Target Upside20.39% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Earnings And GuidanceAnalyst notes that sales and earnings beat expectations and management raised the midpoint of fiscal 2026 EPS guidance, which could support upward pressure on the share price.
Free Cash Flow And BuybacksManagement reiterated strong free cash flow exceeding $245 million for the fiscal year, enabling accelerated share repurchases and preserving capital allocation optionality.
Valuation Versus PeersThe stock trades at a low-teens multiple compared with higher multiples for large-cap peers, presenting an attractive valuation case for value-oriented investors.
Bears Say
Eye Care Supply ConstraintsPersistent eye care supply issues are weighing on sales while the company works to restore normal distribution, posing downside risk to revenue recovery.
Organic Sales SoftnessOrganic sales fell due to anticipated supply constraints despite some timing benefits from Clear Eyes and elevated e-commerce orders, indicating demand stability remains uncertain.
Regional Sales WeaknessNorth America sales declined as ongoing eye care constraints depressed demand in the core market, which could slow overall top-line momentum.
Prestige Consumer Healthcare News
PBH FAQ
What was Prestige Consumer Healthcare’s price range in the past 12 months?
Prestige Consumer Healthcare lowest stock price was $57.25 and its highest was $90.04 in the past 12 months.
What is Prestige Consumer Healthcare’s market cap?
Prestige Consumer Healthcare’s market cap is $3.08B.
When is Prestige Consumer Healthcare’s upcoming earnings report date?
Prestige Consumer Healthcare’s upcoming earnings report date is Feb 05, 2026 which is in 25 days.
How were Prestige Consumer Healthcare’s earnings last quarter?
Prestige Consumer Healthcare released its earnings results on Nov 06, 2025. The company reported $1.07 earnings per share for the quarter, beating the consensus estimate of $0.97 by $0.1.
Is Prestige Consumer Healthcare overvalued?
According to Wall Street analysts Prestige Consumer Healthcare’s price is currently Undervalued.
Does Prestige Consumer Healthcare pay dividends?
Prestige Consumer Healthcare pays a Notavailable dividend of $0.475 which represents an annual dividend yield of N/A. See more information on Prestige Consumer Healthcare dividends here
What is Prestige Consumer Healthcare’s EPS estimate?
Prestige Consumer Healthcare’s EPS estimate is 1.14.
How many shares outstanding does Prestige Consumer Healthcare have?
Prestige Consumer Healthcare has 48,084,010 shares outstanding.
What happened to Prestige Consumer Healthcare’s price movement after its last earnings report?
Prestige Consumer Healthcare reported an EPS of $1.07 in its last earnings report, beating expectations of $0.97. Following the earnings report the stock price went up 2.557%.
Which hedge fund is a major shareholder of Prestige Consumer Healthcare?
Currently, no hedge funds are holding shares in PBH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Prestige Consumer Healthcare Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$77.00 (20.39% Upside)
$77.00 (20.39% Upside)
Blogger Sentiment
Bullish
PBH Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 1.6M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $238.1K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-20.37%
12-Months-Change
Fundamentals
Return on Equity
11.29%
Trailing 12-Months
Asset Growth
3.78%
Trailing 12-Months
Company Description
Prestige Consumer Healthcare
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
PBH Company Deck
PBH Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted strong growth in e-commerce and effective cost management, along with successful market share expansion in the dental category. However, challenges with Clear Eyes supply constraints and declining revenue due to lower sales in key categories were noted. Investment in marketing and strategic acquisitions are expected to support future growth.View all PBH earnings summariesPBH Stock 12 Month Forecast
Average Price Target
$77.00
▲(20.39% Upside)
Technical Analysis
Cardinal Health
―
Henry Schein
―
McKesson
―
―
Guardian Pharmacy Services, Inc. Class A
―
Ownership Overview
Currently, No data available
---